Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323307 · ClinicalTrials.gov registry record · NA
Low Cost OCT for Point of Care
A NA study of Optical Coherence Tomography (OCT) of the Retina, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03323307: Completed NA study of Optical Coherence Tomography (OCT) of the Retina, sponsored by Duke University.
NCT03323307 is a NA study of Optical Coherence Tomography (OCT) of the Retina that has completed, run by Duke University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03323307, a NA study of Optical Coherence Tomography (OCT) of the Retina, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the performance of a prototype optical coherence tomography (OCT) machine with currently available high resolution OCT machines.
Primary Outcome
measured by: ability to see clearly defined and recognizable structures of the retina with the low cost OCT device
Conditions Studied
Interventions
- DEVICE OCT imaging
Study Locations (1)
North Carolina
- University of North Carolina Kittner Eye Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT03323307 record still lists
NCT03323307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Optical Coherence Tomography (OCT) of the Retina appearing as the primary indexed condition, and to 1 intervention - of which OCT imaging is the first listed.
NCT03323307 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03323307 about?
NCT03323307 is a clinical study titled "Low Cost OCT for Point of Care". The purpose of this study is to compare the performance of a prototype optical coherence tomography (OCT) machine with currently available high resolution OCT machines.
What is the current status of trial NCT03323307?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-03-28. Estimated completion is 2018-12-13.
What conditions does trial NCT03323307 study?
This clinical trial studies the following conditions: Optical Coherence Tomography (OCT) of the Retina.
What interventions are being tested in trial NCT03323307?
The interventions under investigation include: OCT imaging (DEVICE).
Who is sponsoring clinical trial NCT03323307?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03323307 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03323307's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI